Stock Events

Stock Events

Outlook Therapeutics (OTLK) Q2 2026 Earnings

15MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-0.44

-0.31

-0.19

-0.06

Details

Expected EPS

-0.121167

Actual EPS

-0.16

Surprise EPS

-0.04

Surprise Percent

+32.05%

Description

Outlook Therapeutics (OTLK) has reported earnings of -0.16 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.